1. Home
  2. HPE vs RMD Comparison

HPE vs RMD Comparison

Compare HPE & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hewlett Packard Enterprise Company

HPE

Hewlett Packard Enterprise Company

HOLD

Current Price

$24.54

Market Cap

31.5B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$244.23

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPE
RMD
Founded
1939
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HPE
RMD
Price
$24.54
$244.23
Analyst Decision
Buy
Buy
Analyst Count
18
13
Target Price
$26.13
$289.09
AVG Volume (30 Days)
28.9M
921.1K
Earning Date
12-04-2025
01-29-2026
Dividend Yield
2.38%
0.99%
EPS Growth
N/A
29.59
EPS
N/A
9.77
Revenue
$34,296,000,000.00
$5,257,400,000.00
Revenue This Year
$20.01
$9.85
Revenue Next Year
$5.35
$7.32
P/E Ratio
N/A
$24.82
Revenue Growth
13.84
9.36
52 Week Low
$11.97
$199.92
52 Week High
$26.44
$293.81

Technical Indicators

Market Signals
Indicator
HPE
RMD
Relative Strength Index (RSI) 60.08 40.67
Support Level $23.39 $241.66
Resistance Level $24.67 $255.83
Average True Range (ATR) 0.93 5.07
MACD 0.16 -0.51
Stochastic Oscillator 82.40 13.09

Price Performance

Historical Comparison
HPE
RMD

About HPE Hewlett Packard Enterprise Company

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: